Talphera News and Activities

Talphera is a company listed under the stock ticker TLPH (US).

View the org chart displaying its 13 main executives

Most searched biographies at Talphera

• Vincent Angotti, Chief Executive Officer and Director
• Marina Bozilenko, Independent Director
• Adrian Adams, Chairman of the Board

Popular executive movements at Talphera

• Joe Todisco has joined the company as Director  (posted on October 21 2025).
• Joe Todisco has joined the company as Director  (posted on October 21 2025).

Create your alert
to follow the executive moves at Talphera.

Talphera has 1,913 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).
• Polpharma has acquired Biofarm (posted on June 24 2026).
• AbbVie has announced the acquisition of Apogee Therapeutics  (posted on June 23 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Talphera

• AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020 | AcelRx Pharmaceuticals, Inc.
• AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA® | AcelRx Pharmaceuticals, Inc.
• AcelRx Awarded U.S. Army Contract for DSUVIA® | AcelRx Pharmaceuticals, Inc.
• AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary | AcelRx Pharmaceuticals, Inc.
• AcelRx Pharmaceuticals to Present at Two Upcoming Conferences | AcelRx Pharmaceuticals, Inc.
• AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative Setting | AcelRx Pharmaceuticals, Inc.
• AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA® | AcelRx Pharmaceuticals, Inc.
• AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results | AcelRx Pharmaceuticals, Inc.
• AcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020 | AcelRx Pharmaceuticals, Inc.
• AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA® | AcelRx Pharmaceuticals, Inc.
• View more press releases Close

Social media about Talphera

• Talphera on Wikipedia, Google News & Yahoo Finance
• Talphera on LinkedIn, X (Twitter) & YouTube